# Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

> **NCT07663643** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 459 (estimated)

## Conditions studied

- Metabolic Dysfunction-associated Fatty Liver Cirrhosis

## Interventions

- **DRUG:** Fuzheng Huayu Tablets

## Key facts

- **NCT ID:** NCT07663643
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-25
- **Primary completion:** 2027-10-15
- **Final completion:** 2029-04-02
- **Target enrollment:** 459 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663643, "Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07663643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*